Common Contracts
2 similar License and Collaboration Agreement contracts by Spectrum Pharmaceuticals Inc
AMENDMENT TO LICENSE AND COLLABORATION AGREEMENTLicense and Collaboration Agreement • November 18th, 2013 • Spectrum Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Amendment (this “Amendment”), effective as of October 3, 2013 (the “Amendment Date”) is made by and between Topotarget A/S, a Danish corporation having its principal offices at Symbion Science Park, Fruebjergvej 3, 2100 København, Denmark (“Topotarget”), and Spectrum Pharmaceuticals, Inc., a Delaware corporation having a place of business at 11500 S. Eastern Avenue, Suite 240, Henderson, Nevada 89052 U.S.A. (“Spectrum”), and amends the License and Collaboration Agreement, dated February 2, 2010, by and between Spectrum and Topotarget (the “License Agreement”). Topotarget and Spectrum are sometimes referred to herein individually as a “Party” and collectively as the “Parties”. Any capitalized terms used but not defined herein will have the meaning ascribed to such terms in the License Agreement.
AMENDMENT TO LICENSE AND COLLABORATION AGREEMENTLicense and Collaboration Agreement • October 7th, 2013 • Spectrum Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Amendment (this “Amendment”), effective as of October 3, 2013 (the “Amendment Date”) is made by and between Topotarget A/S, a Danish corporation having its principal offices at Symbion Science Park, Fruebjergvej 3, 2100 København, Denmark (“Topotarget”), and Spectrum Pharmaceuticals, Inc., a Delaware corporation having a place of business at 11500 S. Eastern Avenue, Suite 240, Henderson, Nevada 89052 U.S.A. (“Spectrum”), and amends the License and Collaboration Agreement, dated February 2, 2010, by and between Spectrum and Topotarget (the “License Agreement”). Topotarget and Spectrum are sometimes referred to herein individually as a “Party” and collectively as the “Parties”. Any capitalized terms used but not defined herein will have the meaning ascribed to such terms in the License Agreement.
